You are currently viewing What Are GLP-1 Weight Loss Medications

What Are GLP-1 Weight Loss Medications

  • Post last modified:March 31, 2026
  • Reading time:5 mins read

What Are GLP-1 Weight Loss Medications?

How GLP-1 Medications Support Weight Loss

GLP-1 weight loss medications have been increasingly used as part of medically supervised weight management programs. These treatments are designed to support appetite control, improve metabolic function, and assist with sustainable weight loss over time. As awareness continues to grow, patients are seeking reliable information about how these medications work and what results may be expected. At Padgett Medical Center, personalized treatment plans are developed to help patients achieve safe and effective weight loss outcomes.

Start Your Personalized Weight Loss Plan

A medically supervised approach to weight loss can provide structure, accountability, and proven results. At Padgett Medical Center, personalized compounded GLP-1 treatments are offered to help patients achieve meaningful progress.

Schedule a consultation today to learn whether semaglutide or tirzepatide may be the right option for your weight loss journey.

Why GLP-1 Weight Loss Treatments Are Effective

GLP-1 medications are designed to work with the body’s natural systems to support weight loss. Appetite is regulated, metabolism is supported, and consistent results may be achieved over time.

With personalized compounded semaglutide and personalized compounded tirzepatide available, patients are provided with targeted solutions that are tailored to their individual needs.

Start Your Personalized Weight Loss Plan Today

At Padgett Medical Center, every program is tailored to the individual. Whether you choose semaglutide or tirzepatide, your treatment plan is designed to help you achieve safe, sustainable results.

Frequently Asked Questions

GLP-1 stands for glucagon-like peptide-1, a hormone that helps regulate appetite and blood sugar levels.

Results may vary, but studies have shown that patients may lose up to 20% or more of their starting weight with consistent treatment.

Semaglutide targets GLP-1 receptors, while tirzepatide targets multiple receptors, which may lead to enhanced weight loss results.

These medications are considered safe when prescribed and monitored by a medical professional.

Treatment duration varies based on individual goals and progress. Ongoing evaluation is conducted throughout the process.

* Compounded semaglutide and tirzepatide are compounded drugs that have not been approved by the FDA; have not been reviewed by the FDA for safety, effectiveness, or quality; and have not been demonstrated to the FDA to be safe or effective for their intended use; the processes by which the compounded drugs are manufactured have not been reviewed by the FDA; and FDA-approved products containing semaglutide and tirzepatide are available. However, the processes by which drugs are compounded are reviewed and regulated by the State Board of Pharmacy under the US Pharmacopeia standards for sterile compounding.